The categorization of hereditary MTC into moderate, high, or highest risk based on the codon of the RET proto-oncogene mutated is relevant when the tumor is early, but not when it is advanced, as the outcome is similar for advanced stages of the disease [94]. This evidence concerns the gene RET and neoplasm.